What are the side effects of dexamethasone, including short‑term and long‑term adverse effects, and how should they be monitored and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Side Effects of Dexamethasone

Dexamethasone carries significant dose-dependent and duration-dependent adverse effects, with serious complications occurring in 11-14% of patients on high-dose therapy, including severe psychoses, gastrointestinal ulcers requiring surgery, hemorrhage, and perforations. 1

Short-Term Adverse Effects (Within Days to Weeks)

Common Side Effects

The most frequently reported short-term adverse effects include:

  • Insomnia (31-45% of patients) - most common complaint 2, 3
  • Gastrointestinal effects: Dyspepsia/epigastric discomfort (21-27%), increased appetite (19%) 3
  • Neuropsychiatric symptoms: Agitation (27%), severe psychoses (in high-dose therapy) 1, 3
  • Metabolic effects: Hyperglycemia, particularly pronounced in diabetic patients 4
  • Weight gain (16-47 pounds in pregnant women on prolonged therapy) 3, 5
  • Hiccups, flushing, and increased radicular pain (when used for epidural injections) 6

Serious Short-Term Complications

High-dose dexamethasone (≥96 mg/day) carries an 11% risk of serious toxicity 1, including:

  • Gastric ulcers requiring surgery
  • Gastrointestinal hemorrhage and perforations
  • Rectal bleeding
  • Severe psychoses 1, 7

Critical distinction: The FDA label warns of serious neurologic events including spinal cord infarction, paraplegia, quadriplegia, cortical blindness, and stroke when dexamethasone is used epidurally 8.

Long-Term Adverse Effects (Weeks to Months)

Dose-Dependent Toxicity Pattern

A clear dose-response relationship exists: patients with the greatest dexamethasone exposure (mean 243 mg over 27 days) experienced Grade 3+ adverse events in 65% of cases versus 15% in unexposed patients (OR 15.1,95% CI 1.4-160.8) 9.

Specific Long-Term Effects

Endocrine/Metabolic:

  • Hyperglycemia: Mild increase in non-diabetics (13 mg/dL increase within 12 hours) 4
  • More pronounced in diabetics (32 mg/dL increase) 4
  • Adrenal suppression requiring stress-dose coverage 8
  • Cushingoid features with prolonged use 5

Musculoskeletal:

  • Osteoporosis (requires prophylaxis per guidelines) 10
  • Myopathy 10
  • Osteonecrosis 10

Dermatologic:

  • Acne (15%) 3
  • Severe striae resulting in permanent scarring 5
  • Skin atrophy 10

Ophthalmologic:

  • Posterior subcapsular cataracts 8
  • Glaucoma with possible optic nerve damage 8

Infectious:

  • Increased infection risk (17% in cancer patients) 9
  • Decreased resistance and inability to localize infections 8
  • Reactivation of latent infections (amebiasis) 8

Cardiovascular:

  • Hypertension 10, 5
  • Fluid retention 8

Special Population: Neonates

Critical neurodevelopmental concerns: High-dose dexamethasone (≥0.5 mg/kg/day) in neonates causes:

  • Neurodevelopmental impairment 11
  • Decreased hippocampal volume 11
  • Altered hippocampal synaptic plasticity and memory formation 11
  • Degeneration and necrosis of hippocampal neurons (animal models) 11

This contrasts with hydrocortisone, which shows no such effects, likely due to dexamethasone's selective glucocorticoid receptor binding versus hydrocortisone's dual mineralocorticoid/glucocorticoid receptor activity 11.

Monitoring Strategy

Baseline Assessment

Before initiating dexamethasone, evaluate for contraindications 10:

  • Diabetes or glucose intolerance
  • Cardiovascular disease
  • Peptic ulcer disease
  • Recurrent infections or immunosuppression
  • Glaucoma risk factors
  • Osteoporosis risk

Active Monitoring Protocol 10

Monitor for:

  • Glucose levels: Particularly in diabetics and during first 24 hours
  • Blood pressure: Regular monitoring for hypertension
  • Weight: Track for excessive gain
  • Infections: Heightened surveillance
  • Neuropsychological changes: Mood, sleep, psychosis
  • Gastrointestinal symptoms: Epigastric pain, bleeding
  • Ophthalmologic screening: For cataracts and glaucoma with prolonged use

Management Strategies

Dose Optimization

Use the minimum effective dose 1:

  • Standard dose: ≤6 mg/day for most indications (used in 80% of COVID-19 hospitalizations) 12
  • High-dose therapy (>10 mg/day): Reserve only for specific indications (spinal cord compression, cerebral edema) where benefits clearly outweigh risks 1, 7, 8
  • Avoid prolonged high-dose therapy: Serious adverse effects increase from 0% with moderate doses to 14% with high doses 1

Duration Minimization

  • Limit treatment to <14 days when possible 13
  • Rapid taper: Can be accomplished in 2-3 days for most patients after short courses 13
  • Avoid abrupt discontinuation after prolonged use (>few days) to prevent adrenal insufficiency 8

Prophylactic Measures

Osteoporosis prevention 10:

  • Calcium and vitamin D supplementation
  • Bisphosphonates for high-risk patients
  • Weight-bearing exercise

Gastrointestinal protection:

  • PPI co-prescription shows no significant benefit in reducing GI side effects 13
  • Use selectively based on individual risk factors rather than routinely

Infection prevention:

  • Avoid live vaccines during immunosuppressive therapy 8
  • Screen for latent infections (tuberculosis, amebiasis) before prolonged therapy 8
  • Counsel patients on infection risk, particularly chickenpox and measles exposure 8

Glucose management:

  • More intensive monitoring in diabetics
  • Adjust antihyperglycemic medications proactively 4

Stress-Dose Coverage

Patients on prolonged dexamethasone require increased dosing during physiologic stress (surgery, infection, trauma) due to HPA axis suppression 8. Consider mineralocorticoid supplementation as dexamethasone lacks sodium-retaining properties 8.

Common Pitfalls to Avoid

  1. Prescribing high doses (>10 mg/day) without clear indication: Over 20% of COVID-19 patients requiring minimal oxygen received inappropriately high doses 12

  2. Prolonging therapy unnecessarily: Each additional week increases adverse event risk substantially 9

  3. Routine PPI co-prescription: Not evidence-based and adds unnecessary medication burden 13

  4. Inadequate patient counseling: Patients must understand expected side effects (insomnia, mood changes, increased appetite) to maintain compliance and report serious symptoms early 10

  5. Abrupt discontinuation: After >few days of treatment, taper gradually to avoid adrenal crisis 8

  6. Ignoring drug interactions: Particularly with amphotericin B (cardiac complications) and NSAIDs (increased GI perforation risk in neonates) 11, 8

References

Research

Adverse side effects of dexamethasone in surgical patients.

The Cochrane database of systematic reviews, 2018

Research

Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.

The Journal of clinical endocrinology and metabolism, 1992

Research

A 10-year retrospective observational study on the utility and prescription standards of dexamethasone in pediatric neuro-oncosurgery in a tertiary care center.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.